Monitor for any future conversion to a Schedule 13D, which would signal activist intent. The incremental increase is modest and consistent with passive portfolio rebalancing — no immediate catalyst.
Price Chart
Executive Summary
Millennium Management LLC and affiliated entities filed an amended Schedule 13G, disclosing a 8.7% beneficial ownership stake in vTv Therapeutics Inc. as of September 30, 2026. This represents a slight increase from the prior filing's 7.9% stake held by Integrated Core Strategies (US) LLC, indicating continued passive conviction from the multi-strategy hedge fund.
Key Financial Metrics
Key Facts
- Millennium Management LLC and affiliates now beneficially own 342,481 shares of vTv Therapeutics Class A Common Stock, representing 8.7% of shares outstanding.
- The prior filing (July 2026) showed Integrated Core Strategies (US) LLC holding 312,138 shares (7.9%), so the overall stake increased by approximately 30,343 shares.
- The filing is a passive Schedule 13G/A under Rule 13d-1(c), confirming the position is not held with activist intent.
- Israel A. Englander is the ultimate beneficial owner through Millennium Group Management LLC and Millennium Management LLC.
Financial Impact
Millennium's stake value is approximately $1.7 million based on a ~$5.00/share price (estimated from prior filings). No material financial impact from the filing itself.
Risk Factors
- Millennium could reduce or exit the position at any time, given its multi-strategy hedge fund structure.
- The filing does not disclose any plans or proposals for changes at the company.
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| SC 13G/A Filing (Primary) | 0001104659-26-114761 |
| Document: 0001104659-26-114761-index-headers.html | 0001104659-26-114761 |
| Document: 0001104659-26-114761-index.html | 0001104659-26-114761 |
| Document: 0001104659-26-114761.txt | 0001104659-26-114761 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 8, 2026 17d ago | SC 13G/A | $31.18 | awaiting T+20 | — | $25.85 (−17.08%) |
Jun 10, 2026 19w ago | DEFA14A | $31.59 $33.44 | ▲ +5.86% | ▲ +3.97% | $25.85 (−18.15%) |
May 8, 2026 24w ago | Press Release | $30.46 $31.77 | ▲ +4.30% | ▲ +4.61% | $25.85 (−15.12%) |
Mar 10, 2026 32w ago | Press Release | $35.10 $37.30 | ▲ +6.27% | ▲ +5.74% | $25.85 (−26.34%) |
Feb 26, 2026 34w ago | 8-K | $39.32 $37.80 | ▼ −3.87% | ▲ +2.54% | $25.85 (−34.24%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers